Report #2890135

Received Mar 20, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: GA
Recovered: Unknown
Vaccinated: Mar 6, 2026
Onset: Mar 6, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RV1	ROTAVIRUS (ROTARIX)	GLAXOSMITHKLINE BIOLOGICALS	2	94A7Z	PO / MO

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

inappropriate vaccination schedule; This non-serious case was reported by a other health professional and described the occurrence of drug dose administration interval too short in a 6-month-old female patient who received Rota (Rotarix liquid formulation) (batch number 94A7Z, expiry date 01-JUL-2027) for prophylaxis. Concomitant products included ROTAVIRUS VACCINE LIVE ORAL 1V (ROTARIX). On 06-MAR-2026, the patient received the 2nd dose of Rotarix liquid formulation (oral) 1.5 ml. On 06-MAR-2026, an unknown time after receiving Rotarix liquid formulation, the patient experienced drug dose administration interval too short (Verbatim: inappropriate vaccination schedule). The outcome of the drug dose administration interval too short was not applicable. Additional Information: GSK Receipt Date: 13-MAR-2026 The patient was administered with two Rota vaccines one on 26-FEB-2026 and 06-MAR-2026 The batch number was not provided and a request for this information has been made.